SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-019519
Filing Date
2021-08-12
Accepted
2021-08-12 16:21:09
Documents
71
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1001775
2 ex31-1.htm EX-31.1 10317
3 ex31-2.htm EX-31.2 10432
4 ex32-1.htm EX-32.1 4541
5 ex32-2.htm EX-32.2 4501
  Complete submission text file 0001493152-21-019519.txt   5545440

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE vvos-20210630.xsd EX-101.SCH 45074
7 XBRL CALCULATION FILE vvos-20210630_cal.xml EX-101.CAL 61994
8 XBRL DEFINITION FILE vvos-20210630_def.xml EX-101.DEF 177099
9 XBRL LABEL FILE vvos-20210630_lab.xml EX-101.LAB 384461
10 XBRL PRESENTATION FILE vvos-20210630_pre.xml EX-101.PRE 305542
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 806055
Mailing Address 9137 RIDGELINE BOULEVARD SUITE 135 HIGHLANDS RANCH CO 80129
Business Address 9137 RIDGELINE BOULEVARD SUITE 135 HIGHLANDS RANCH CO 80129 (866)908-4867
Vivos Therapeutics, Inc. (Filer) CIK: 0001716166 (see all company filings)

IRS No.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39796 | Film No.: 211167871
SIC: 3841 Surgical & Medical Instruments & Apparatus